The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.

Sci Rep

Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL 32224, USA.

Published: September 2016

Increased expression of PRKD1 and its gene product protein kinase D1 (PKD1) are linked to oncogenic signaling in pancreatic ductal adenocarcinoma, but a direct functional relationship to oncogenic KRas has not been established so far. We here describe the PRKD1 gene promoter as a target for oncogenic KRas signaling. We demonstrate that KRas-induced activation of the canonical NF-κB pathway is one mechanism of how PRKD1 expression is increased and identify the binding sites for NF-κB in the PRKD1 promoter. Altogether, these results describe a novel mechanism governing PRKD1 gene expression in PDA and provide a functional link between oncogenic KRas, NF-κB and expression of PRKD1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030668PMC
http://dx.doi.org/10.1038/srep33758DOI Listing

Publication Analysis

Top Keywords

prkd1 gene
12
oncogenic kras
12
prkd1 promoter
8
promoter target
8
expression prkd1
8
prkd1
7
target kras-nf-κb
4
kras-nf-κb pathway
4
pathway pancreatic
4
pancreatic cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!